Reaching multidisciplinary consensus on classification of anaphylaxis for the eleventh revision of the World Health Organization's (WHO) International Classification of Diseases (ICD-11).
Reaching multidisciplinary consensus on classification of anaphylaxis for the eleventh revision of the World Health Organization's (WHO) International Classification of Diseases (ICD-11).
复制标题
DOI：
10.1186/s13023-017-0607-3
复制
发表时间：
2017-03-16
影响因子：
3.7
通讯作者：
on behalf the Joint Allergy Academies
中科院分区：
文献类型：
--
作者：
Tanno LK;Chalmers RJ;Calderon MA;Aymé S;Demoly P;on behalf the Joint Allergy Academies
虽然目前在国际疾病分类（ICD）中被错误分类，并且尚未正式列为罕见疾病，但过敏反应是一种众所周知的临床紧急情况。过敏反应现在是即将出版的ICD-11第11次修订版中“过敏和超敏反应”一节的主要标题之一。我们在此报告ICD-11中开创性的“过敏反应”小节的构建过程，我们的目标是按照ICD-11修订指南的建议实现透明度。在与ICD-11主题咨询小组和专家工作组进行的在线密集科学和技术讨论中，我们共起草了35份过敏反应分类提案。在所有35项建议中，77%已获实施，20%有待实施，其余部分实施（1.5%）或被拒绝（1.5%）。这是第一次，过敏反应现在被正确分类，并在ICD中获得了更大的可见性。除了我们在更新ICD-11中过敏和超敏反应的术语、定义和分类方面所采取的行动所预期的所有益处外，我们坚信过敏反应应成为公共卫生的优先事项，因此应正式将其添加到罕见病列表中，以支持对患者的认识和高质量的临床管理。
Although currently misclassified in the International Classification of Diseases (ICD) and still not officially listed as a rare disease, anaphylaxis is a well-known clinical emergency. Anaphylaxis is now one of the principal headings in the “Allergic and hypersensitivity conditions” section recently compiled for the forthcoming 11th Revision of ICD (ICD-11). We here report the building process used for the pioneering “Anaphylaxis” subsection of ICD-11 in which we aimed for transparency as recommended in the ICD-11 revision guidelines. During an online intensive scientific and technical discussions with ICD-11 Topic Advisory Groups and Expert Working Groups, we drafted a total of 35 proposals for the classification of anaphylaxis. From all the 35 proposals, 77% were implemented, 20% remain to be implemented, and the others being partially implemented (1.5%) or rejected (1.5%). For the first time, anaphylaxis is now properly classified and has attained greater visibility within ICD. In addition to all the benefits expected from the actions we have undertaken in updating the terminology, definitions and classification of allergic and hypersensitivity conditions for ICD-11, we strongly believe that anaphylaxis should be a public health priority and that it should therefore be formally added into the list of rare diseases in order to support awareness and quality clinical management of patients.